A collaborative team of scientists from institutions across Philadelphia and the country just received a $37.6 million grant to continue research and preclinical development of DNA-encoded monoclonal antibodies (DMAbs), which early findings show could help a person fight off or prevent infection of COVID-19.

It’s yet another look at how local researchers are playing a role in the fight against the coronavirus pandemic.

The research comes out of the lab of Wistar Institute EVP David Weiner, in collaboration with scientists from Inovio Pharmaceuticals, AstraZeneca, University of Pennsylvania’s Perelman School of Medicine and Indiana University.

READ FULL ARTICLE HERE